This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Cancer of liver and bile duct
  • /
  • EASL Clinical Practice Guidelines: Management of h...

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Read time: 1 mins
Last updated:30th Jun 2018

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.


Read full guideline